featured
A Blood-Based Assay for Assessment of Tumor Mutational Burden in First-Line Metastatic NSCLC Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Blood-Based Assay for Assessment of Tumor Mutational Burden in First-Line Metastatic NSCLC Treatment: Results From the MYSTIC Study
Clin. Cancer Res 2020 Dec 22;[EPub Ahead of Print], H Si, M Kuziora, KJ Quinn, E Helman, J Ye, F Liu, U Scheuring, S Peters, NA Rizvi, P Brohawn, K Ranade, BW Higgs, KC Banks, VK Chand, R RajaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.